BusinessActinium Pharmaceuticals Receives Clearance from Health Canada to Initiate Pivotal Phase 3 SIERRA Trial of Iomab-BBy Nasdaq OMXMay 10, 2017, 11:01 AM UTC
BusinessActinium Pharmaceuticals Receives Clearance from Health Canada to Initiate Pivotal Phase 3 SIERRA Trial of Iomab-BBy Nasdaq OMXMay 10, 2017, 11:01 AM UTC
BusinessActinium Pharmaceuticals Announces Sponsorship of the Acute Leukemia Forum 2017By Nasdaq OMXApr 18, 2017, 11:00 AM UTC
BusinessActinium Pharmaceuticals Appoints Pharmaceutical Industry Executive Ajit S. Shetty, Ph.D., to the Company’s Board of DirectorsBy Nasdaq OMXMar 28, 2017, 11:02 AM UTC
BusinessActinium Pharmaceuticals Appoints Pharmaceutical Industry Executive Ajit S. Shetty, Ph.D., to the Company’s Board of DirectorsBy Nasdaq OMXMar 28, 2017, 11:02 AM UTC
BusinessActinium Announces Receipt of Positive Scientific Advice from the European Medicines Agency for Iomab-BBy Nasdaq OMXMar 21, 2017, 11:02 AM UTC
BusinessActinium Announces Receipt of Positive Scientific Advice from the European Medicines Agency for Iomab-BBy Nasdaq OMXMar 21, 2017, 11:02 AM UTC
BusinessActinium Announces Receipt of Positive Scientific Advice from the European Medicines Agency for Iomab-BBy Nasdaq OMXMar 21, 2017, 11:02 AM UTC
